Improving Pharma R&D Efficiency

With development cycles becoming too long, trial complexity increasing, and greater scrutiny of the economic value of new treatments, pharma R&D business models are under significant pressures to improve R&D efficiency. In an ICON industry survey of pharmaceutical executives and professionals on Pharma R&D Efficiency, the challenges most frequently cited are explored. Learn more in this Applied Clinical Trials Industry Trends 2019 article.